The health tech and medtech investment landscape in the age of Covid-19
Fredrikson & Byron attorneys Ryan Johnson and Jeffrey Steinle share insights on how Covid-19 is continuing to transform the health tech and medtech landscape.
The legal ramifications of rapidly scaling telehealth (Q&A)
What are some of the short- and long-term consequences of these moves, and what does the future portend? In a Q&A, Fredrikson & Byron Shareholders Ryan Johnson and Katherine Ilten share their insights on this hot topic.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Healthcare must overcome AI’s ‘Black Box’ problem
For artificial intelligence to gain wider interest from clinicians, the way the algorithms arrive at their conclusions needs to be understandable.